Home » Topics » BioWorld Science

BioWorld Science
RSS

Endothelin antagonists revealed by Fujisawa

May 31, 1996

Sanofi Winthrop research reveals elastase inhibitors

May 31, 1996

Small-molecule alpha4 integrin antagonists generation disclosed by Biogen

May 31, 1996

Nikken Chemicals reports antiallergic/antiinflammatory N-hydroxyureas

May 31, 1996

Medeva owns U.S. rights to acrivastine/pseudoephedrine HCI

May 31, 1996

FDA approval for RPR's new triamcinolone acetonide formulation

May 31, 1996

Hyaluronic acid and derivatives described by Hyal

May 31, 1996

Production of recombinant human basic fibroblast growth factor covered by U.S. patent

May 31, 1996

Neurotrophic polypeptides disclosed by Children's Medical Center

May 31, 1996

Gedeon Richter discloses antiamnestic ethers

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...